Drug Trial Radar · NCT05556512
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
15,374
Actual
Start
Oct 11, 2022
Primary completion
Oct 2027
Study completion Oct 2027
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Sep 27, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additional evidence for the potential clinical benefits of tirzepatide in this population.
Conditions
- Obesity
- Overweight
Interventions
TirzepatideDrug
Administered SC
PlaceboDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to First Occurrence of Any Component Event of Composite (All-Cause Death, Nonfatal Myocardial Infarction (MI), Nonfatal Stroke, Coronary Revascularization, or Heart Failure Events)Time frame: Up to 5 Years
Locations
672 sites in 28 countries. Site status is shown where the registry gives one.
Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC
Gilbert, Arizona
Aventiv Research
Mesa, Arizona
Elite Clinical Studies
Phoenix, Arizona
Pima Heart
Tucson, Arizona
KLR Business Group, Inc. dba Arkansas Clinical Research
Little Rock, Arkansas
Smart Cures Clinical Research
Anaheim, California
Trident Clinical Research Services, Inc.
Apple Valley, California
Hope Clinical Research, Inc.
Canoga Park, California
John Muir Physician Network Research Center
Concord, California
Neighborhood Healthcare Institute of Health
Escondido, California
HB Clinical Trials - Fountain Valley
Fountain Valley, California
Valiance Clinical Research
Huntington Park, California
Scripps Whittier Diabetes Institute
La Jolla, California
Velocity Clinical Research, San Diego
La Mesa, California
First Valley Medical Group
Lancaster, California
Long Beach Clinical Trials
Long Beach, California
Infinity Clinical Research - Norco
Norco, California
California Medical Research Associates
Northridge, California
Diabetes Associates Medical Group
Orange, California
University of California Irvine Medical Center
Orange, California
FOMAT Medical Research
Oxnard, California
Desert Oasis Healthcare Medical Group
Palm Springs, California
Dream Team Clinical Research
Pomona, California
Rancho Cucamonga Clinical Research
Rancho Cucamonga, California
Artemis Institute for Clinical Research
Riverside, California
Acclaim Clinical Research
San Diego, California
Artemis Institute for Clinical Research
San Diego, California
Velocity Clinical Research, Santa Ana
Santa Ana, California
Valiance Clinical Research
Tarzana, California
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Torrance, California
Diablo Clinical Research, Inc.
Walnut Creek, California
Millennium Clinical Trials
Westlake Village, California
University of Colorado Anschutz Medical Campus
Aurora, Colorado
Optum- Southwestern
Colorado Springs, Colorado
Kidney Associates of Colorado
Denver, Colorado
OptumCare Clinical Trials, LLC
Golden, Colorado
Clinical Research Consulting
Milford, Connecticut
Cardiology Associates of Fairfield County, P.C.
Stamford, Connecticut
Chase Medical Research, LLC
Waterbury, Connecticut
Excel Medical Clinical Trials
Boca Raton, Florida
Showing 40 of 672 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.